I mean, when we talk about obesity being a chronic disease, you know, for a long time on the medical management side, we didn't really have a lot of great options that gave us great results," said Piedmont Columbus Regional, Surgeon and Obesity management specialist, Kenneth Copperwheat
Unlike the small molecule CB1 inhibitors currently in development, nimacimabs differentiating peripheral restriction has the potential to demonstrate the same weight loss and metabolic benefits previously seen in clinical trials by first-generation CB1 inhibitors, without the significant neuropsychiatric liabilities that continue to plague its small molecule counterparts
Members will be notified as soon as newly cleared peptides become available
To the patients using Ozempic for Type 2 diabetes, Mounjaro may be preferred since it is similar to Zepbound but was developed for diabetes treatment purposes
Injectable Peptides Injectable peptides are more experimental